Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

30.86
Delayed Data
As of Apr 27
 +0.28 / +0.92%
Today’s Change
25.55
Today|||52-Week Range
35.04
+12.96%
Year-to-Date

Today’s Trading

Previous close30.58
Today’s open30.58
Day’s range30.53 - 31.07
Volume4,690,020
Average volume (3 months)5,654,145
Market cap$77.4B
Dividend yield4.54%
Data as of 04/27/2017

Growth & Valuation

Earnings growth (last year)+23.59%
Earnings growth (this year)-14.53%
Earnings growth (next 5 years)+0.33%
Revenue growth (last year)-7.37%
P/E ratio22.4
Price/Sales3.03
Price/Book5.16

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories-0.15-0.34%
AGNAllergan+3.55+1.48%
NVONovo Nordisk+1.42+3.80%
BMYBristol-Myers Squibb+1.90+3.53%
Data as of 04/27/2017

Financials

Last reporting dateApril 28, 2017
EPS forecast (this quarter)$0.41
Annual revenue (last year)$22.8B
Annual profit (last year)$3.5B
Net profit margin15.21%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
London, Greater London

Forecasts